Stenobird

Episode

The next era of diabetes management

Podcast
BioSpace
Published
Apr 23, 2026
Duration seconds
1302
Processing state
not_requested
Canonical source
https://api.riverside.com/hosting-analytics/media/7e7cc274bdf350b388b06c34c022a86a40c6aa201ec34db0dd49c372372dfcaa/eyJlcGlzb2RlSWQiOiI3NWU4MGRmNC1hMDE3LTQ3ZTItYTQwOS0zOWI5M2UxNWNjYzMiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNjllOWNmM2Y2ZmRjMTExNjcxOTc4NDQ1L2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi00LTIzX185LTUwLTIzLm1wMyJ9.mp3
Audio
https://api.riverside.com/hosting-analytics/media/7e7cc274bdf350b388b06c34c022a86a40c6aa201ec34db0dd49c372372dfcaa/eyJlcGlzb2RlSWQiOiI3NWU4MGRmNC1hMDE3LTQ3ZTItYTQwOS0zOWI5M2UxNWNjYzMiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNjllOWNmM2Y2ZmRjMTExNjcxOTc4NDQ1L2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi00LTIzX185LTUwLTIzLm1wMyJ9.mp3
JSON
/v1/public/podcasts/biospace-6696251/episodes/the-next-era-of-diabetes-management
Markdown
/podcast/biospace-6696251/the-next-era-of-diabetes-management.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/the-next-era-of-diabetes-management/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/biospace-6696251/the-next-era-of-diabetes-management.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In this episode of Denatured, you'll be hearing from Dr. Sarah Howell, CEO at Arecor Therapeutics and Dr. Wendy S. Lane, clinical endocrinologist and diabetologist. We examine how increasingly connected and tailored diabetes technologies are reframing the field’s central opportunity around minimizing the day-to-day demands of managing the condition.